25th Annual Berkeley-Stanford Advanced Patent Law Institute

Speaking Engagement | December.05.2024 - December.06.2024

Stanford Law School, Paul Brest Hall

Orrick Intellectual Property Partners, Will Melehani and Gargi Talukdar, spoke at the 25th Annual Berkeley-Stanford Advanced Patent Law Institute at Stanford University on December 5-6, 2024. Will Melehani joined the panel on “A Legitimate Alternative? The Rise of Amazon Enforcement Actions,” while Gargi Talukdar discussed “Evolving Double Patenting and Its Impacts on Patent Practice.”

CLE Credits Available: Y

Will Melehani Partner, Propriété intellectuelle

San Francisco

See my bio

D:+1 415 773 5577
E: [email protected]

Practice:

Technology & Innovation Sector
Propriété intellectuelle

vCard

See full bio

Will Melehani Partner

San Francisco

By delving into each case’s complexities and elegantly connecting those details to a broader technical perspective, Will creatively unravels his opposition’s argument.

Will uses this approach to defend cutting edge computer, Internet, software companies and life sciences companies with great success, having prevailed in numerous subject matter eligibility challenges. Will's mastery of patent law also allows him to ensure his strategy will withstand appeal, where Will has frequently played a key role in writing and arguing the appellate briefs. Whether handling patent, trademark or trade secrets matters, Will’s creative methodology gives his clients a unique advantage.

Will is also an enthusiastic participant in Orrick's pro bono efforts, and has obtained successful results for several disadvantaged and low-income pro bono clients.

Gargi Talukder Partner, Propriété intellectuelle, Life Sciences & HealthTech

San Francisco

See my bio

D:+1 415 773 5625
E: [email protected]

Practice:

Propriété intellectuelle
Life Sciences & HealthTech
Patents

vCard

See full bio

Gargi Talukder Partner

San Francisco

Gargi’s work in protein therapeutics includes patent estate development for antibody and fusion protein therapeutics and utilizes her knowledge of the patent landscape in this area to inform strategic portfolio management. In the fields of genomics and proteomics, she has conducted diligence and developed portfolios related to the biochemistry of sequencing technologies, as well as to the associated devices and machine learning methods utilized in sequencing methods. In the field of cancer immunotherapies (immuno-oncology), she has developed portfolios related to cell-based immunotherapy approaches, including targeted immune cell therapies and immunological pathway interventions.

In addition, Gargi assists clients in providing intellectual property support for transactional matters, including diligence for mergers and acquisitions as well as financing rounds. Her technical experience is routinely called upon in helping to develop litigation strategies for complex and high-stakes trials.

Gargi has authored scientific papers in peer-reviewed publications, as well as articles discussing medical and biological research in general-interest newspapers and periodicals. Her doctoral work in Neuroscience from Stanford University focused on structure-function studies in ion channels, with an emphasis on using genetic engineering and electrophysiology to identify structural elements of potassium channels that lead to their voltage and chemical sensitivity.